News & Updates
Filter by Specialty:
Long-term data strengthen TAK-003 potential against dengue
The live-attenuated tetravalent dengue vaccine TAK-003 showed cumulative long-term efficacy in preventing symptomatic dengue caused by all four dengue virus (DENV) serotypes among previously exposed children and adolescents, and by DENV-1 and DENV-2 in dengue-naïve participants in eight* dengue-endemic countries, a study has shown.
Long-term data strengthen TAK-003 potential against dengue
16 May 2024
Biologic DMARDs offer clinical benefits in adult-onset Still disease
Use of biologic disease-modifying antirheumatic drugs (bDMARDs), particularly tocilizumab (TCZ), anakinra (ANK), and canakinumab (CNK), appears safe and effective in the treatment of adult-onset Still disease (AOSD), results of a systematic review and meta-analysis have shown.
Biologic DMARDs offer clinical benefits in adult-onset Still disease
15 May 2024
RSV vaccine plus flu or COVID-19 shots safe, feasible in older adults
Coadministration of mRNA-1345, a respiratory syncytial virus (RSV) vaccine, with an influenza (flu) or a COVID-19 vaccine in older adults exhibits good tolerability and has an acceptable reactogenicity profile, according to a US study presented at ESCMID Global Congress 2024.
